Dapagliflozin (DAPA) Clinical Trials
5 recruitingDrug
Phase 22Phase 42Phase 31
Showing 1–5 of 5 trials
Recruiting
Phase 4
SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes
AtherosclerosisType 2 Diabetes Mellitus (T2DM)Coronary Artery Disease
Junjie Yang144 enrolled2 locationsNCT07614230
Recruiting
Phase 4
The Effect of Dapagliflozin on Patients With Cardiomyopathy
Acute Decompensated Heart Failure (ADHF)
May Mohamed Abdalla100 enrolled1 locationNCT07076615
Recruiting
Phase 3
A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.800 enrolled1 locationNCT07082114
Recruiting
Phase 2
Dapagliflozin in Allo-HCT for aGVHD
Graft-Versus-Host-Disease (GVHD)
The First Affiliated Hospital of Soochow University72 enrolled1 locationNCT06626737
Recruiting
Phase 2
Impact of Dapagliflozin in Anemic Chronic Kidney Disease Patients
Chronic Kidney Disease(CKD)Anemia, Kidney Disease, Chronic
Mansoura University80 enrolled1 locationNCT06897605